AFSTYLA

NDC 69911-476 · CSL Behring Lengnau AG

Generic nameANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT

Dosage formKIT

Marketing categoryBLA

Packages

69911-476-02 — 1 KIT in 1 CARTON (69911-476-02) * 2.5 mL in 1 VIAL, SINGLE-USE (69911-486-01) * 2.5 mL in 1 VIAL, SINGLE-USE (69911-765-83)

J7210 — Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u. Medicare Part B payment limit (ASP + 6%): $1.62

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.